Jan Lanke

10.0k total citations · 3 hit papers
89 papers, 5.7k citations indexed

About

Jan Lanke is a scholar working on Cardiology and Cardiovascular Medicine, Statistics and Probability and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jan Lanke has authored 89 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 12 papers in Statistics and Probability and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jan Lanke's work include Blood Pressure and Hypertension Studies (17 papers), Health disparities and outcomes (10 papers) and Hormonal Regulation and Hypertension (8 papers). Jan Lanke is often cited by papers focused on Blood Pressure and Hypertension Studies (17 papers), Health disparities and outcomes (10 papers) and Hormonal Regulation and Hypertension (8 papers). Jan Lanke collaborates with scholars based in Sweden, United States and Finland. Jan Lanke's co-authors include Thomas Hedner, Lars Lindholm, Ulf dé Fairé, Lennart Hansson, Olle Hagnell, Birgitta Rorsman, Bengt E. Karlberg, Leo Niskanen, Anders Niklason and Bengt Scherstén and has published in prestigious journals such as The Lancet, Journal of the American Statistical Association and Diabetes Care.

In The Last Decade

Jan Lanke

84 papers receiving 5.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 1.5k citations Lennart Hansson, Lars Lindholm et al. The Lancet profile →
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1999 1.0k citations Lennart Hansson, Lars Lindholm et al. The Lancet profile →
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

2000 650 citations Thomas Hedner, Per Lund‐Johansen et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jan Lanke	3.3k	1.9k	559	511	459	89	5.7k
James O. Taylor	2.7k 0.8×	980 0.5×	304 0.5×	602 1.2×	634 1.4×	23	6.0k
Jane Morley Kotchen	1.3k 0.4×	2.5k 1.4×	284 0.5×	424 0.8×	396 0.9×	87	6.8k
Marcel Kornitzer	1.4k 0.4×	885 0.5×	343 0.6×	575 1.1×	334 0.7×	157	6.1k
Michael J. Horan	3.9k 1.2×	1.3k 0.7×	248 0.4×	752 1.5×	884 1.9×	49	6.3k
Richard B. Shekelle	2.5k 0.8×	984 0.5×	211 0.4×	684 1.3×	1.1k 2.4×	83	7.2k
Karin Schenck‐Gustafsson	2.6k 0.8×	1.3k 0.7×	189 0.3×	759 1.5×	150 0.3×	137	6.3k
Riitta Antikaínen	3.3k 1.0×	1.2k 0.7×	528 0.9×	663 1.3×	686 1.5×	128	6.9k
M Feinleib	2.4k 0.7×	1.2k 0.7×	291 0.5×	945 1.8×	295 0.6×	70	6.5k
Millicent Higgins	3.6k 1.1×	1.5k 0.8×	289 0.5×	774 1.5×	857 1.9×	64	8.5k
Yechiel Friedlander	1.2k 0.4×	1.2k 0.6×	269 0.5×	1.3k 2.6×	571 1.2×	207	7.4k

Countries citing papers authored by Jan Lanke

Since Specialization

Citations

This map shows the geographic impact of Jan Lanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lanke more than expected).

Fields of papers citing papers by Jan Lanke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lanke. The network helps show where Jan Lanke may publish in the future.

Co-authorship network of co-authors of Jan Lanke

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lanke. A scholar is included among the top collaborators of Jan Lanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lanke. Jan Lanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Plate, G, Sven Oredsson, & Jan Lanke. (2008). When is Thrombolysis for Acute Lower Limb Ischemia Worthwhile?. European Journal of Vascular and Endovascular Surgery. 37(2). 206–212. 22 indexed citations

Lanke, Jan, et al.. (2003). Relationship between fibrinolytic activity and gingival inflammatory reaction in young individuals. Journal of Periodontal Research. 38(1). 104–108. 8 indexed citations

Kjeldsen, Sverre E., Thomas Hedner, Jan Otto Syvertsen, et al.. (2002). Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study. Journal of Hypertension. 20(6). 1231–1237. 24 indexed citations

Bendz, Hans, Mattias Aurell, & Jan Lanke. (2001). A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed. European Psychiatry. 16(4). 199–206. 44 indexed citations

Lindholm, Lars, Harald Anderson, Tord Ekbom, et al.. (2001). Relation between drug treatment and cancer In hypertenslves in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial. The Lancet. 358(9281). 539–544. 85 indexed citations

Lindholm, Lars, Lennart Hansson, Tord Ekbom, et al.. (2000). Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients. Journal of Hypertension. 18(11). 1671–1675. 142 indexed citations

Hansson, Lennart, Lars Lindholm, Leo Niskanen, et al.. (1999). Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. The Lancet. 353(9153). 611–616. 1480 indexed citations breakdown →

Hansson, Lennart, Lars Lindholm, Tord Ekbom, et al.. (1999). Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. The Lancet. 354(9192). 1751–1756. 1020 indexed citations breakdown →

Iwarsson, Susanne, Åke Isacsson, & Jan Lanke. (1998). ADL dependence in the elderly: The influence of functional limitations and physical environmental demand.. Lund University Publications (Lund University). 12 indexed citations

10.

Ekbom, Tord, Lars Lindholm, Jan Lanke, & Peter Nilsson‐Ehle. (1996). Decrease in high density lipoprotein cholesterol during prolonged storage. Scandinavian Journal of Clinical and Laboratory Investigation. 56(2). 97–101. 7 indexed citations

11.

Lanke, Jan, et al.. (1993). Cold Climate is an Important Factor in Explaining Regional Differences in Coronary Mortality Even if Serum Cholesterol and other Established Risk Factors are Taken into Account. Scottish Medical Journal. 38(6). 169–172. 27 indexed citations

12.

Lanke, Jan, et al.. (1991). High coronary mortality in cold regions of Sweden. Journal of Internal Medicine. 230(6). 479–485. 32 indexed citations

13.

Rorsman, Birgitta, Anne Gräsbeck, Olle Hagnell, et al.. (1990). A Prospective Study of First-Incidence Depression. The British Journal of Psychiatry. 156(3). 336–342. 88 indexed citations

14.

Lanke, Jan, et al.. (1989). A semiautomatic image analyzer for cell counts in monolayers. III. statistical considerations. Journal of Toxicology and Environmental Health. 27(4). 533–545. 3 indexed citations

15.

Rorsman, Birgitta, Olle Hagnell, Jan Lanke, & Leif Öjesjö. (1987). Incidence of Anxiety in the Lundby Study: Changes over Time during a Quarter of a Century. Neuropsychobiology. 18(1). 13–20. 3 indexed citations

16.

Rorsman, Birgitta, Olle Hagnell, & Jan Lanke. (1986). Prevalence and Incidence of Senile and Multi-Infarct Dementia in the Lundby Study: A Comparison between the Time Periods 1947–1957 and 1957–1972. Neuropsychobiology. 15(3-4). 122–129. 87 indexed citations

17.

Rorsman, Birgitta, Olle Hagnell, & Jan Lanke. (1985). Mortality and Age Psychosis in the Lundby Study: Death Risk of Senile and Multi-Infarct Dementia. Neuropsychobiology. 14(1). 13–16. 10 indexed citations

18.

Rorsman, Birgitta, Olle Hagnell, & Jan Lanke. (1983). Mortality and Psychiatric Specialist Care in the Lundby Study. Neuropsychobiology. 9(1). 2–8. 9 indexed citations

19.

Hagnell, Olle, et al.. (1983). Class variations in the incidence of alcoholism in the Lundby Study, Sweden. Social Psychiatry and Psychiatric Epidemiology. 18(3). 123–128. 14 indexed citations

20.

Rorsman, Birgitta, Olle Hagnell, & Jan Lanke. (1982). Violent Death and Mental Disorders in the Lundby Study. Neuropsychobiology. 8(5). 233–240. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact